Physician profile
Jody Comstock
NPI 1437276409
$154,641.47
in general payments reported to CMS, 2019-2025
9 companies · $68K in 2025
The $68K reported for 2025 was more than what 96% of Procedural Dermatology providers received nationally (typical 2025 total: $599).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $26K · 2020: $13K · 2021: $34K · 2022: $10K · 2023: $3,325 · 2024: $965 · 2025: $68K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $58K · Travel and Lodging: $7,938 · Food and Beverage: $3,361 · Consulting Fee: $2,925 · Education: $50.70.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $57,800.00 |
| Travel and Lodging | $7,938.02 |
| Food and Beverage | $3,361.15 |
| Consulting Fee | $2,925.00 |
| Education | $50.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Revance Therapeutics, INC. | $61,844.73 | 2024-2025 | Daxxify, Daxi |
| Allergan, INC. | $47,863.66 | 2019-2022 | |
| Galderma Laboratories, L.P. | $26,047.44 | 2019-2025 | |
| Endo Pharmaceuticals INC. | $8,610.02 | 2019 | |
| Solta Medical, A Division of Bausch Health US, LLC | $6,103.31 | 2019-2025 | |
| Abbvie INC. | $4,111.23 | 2022-2025 | Botox, Skyrizi |
| Vyne Pharmaceuticals INC. | $28.99 | 2021 | |
| Biofrontera INC. | $16.17 | 2021 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $15.92 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jody Comstock listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.